-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 DZplRpn79uR7ChjZn350gS498GigxP0SUBE6wcNGszlV7s/BXF/kA6FToSjYcSTm
 Mv206jeDFcZxqQXb5gxkPQ==

<SEC-DOCUMENT>0001362718-09-000002.txt : 20091120
<SEC-HEADER>0001362718-09-000002.hdr.sgml : 20091120
<ACCEPTANCE-DATETIME>20091120125914
ACCESSION NUMBER:		0001362718-09-000002
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20091120
DATE AS OF CHANGE:		20091120
EFFECTIVENESS DATE:		20091120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TIANYIN PHARMACEUTICAL CO., INC.
		CENTRAL INDEX KEY:			0001362718
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				204857782
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-136310
		FILM NUMBER:		091197957

	BUSINESS ADDRESS:	
		STREET 1:		23RD FLOOR, UNIONSUN YANGKUO PLAZA
		STREET 2:		NO.2, BLOCK 3, RENMIN ROAD SOUTH
		CITY:			CHENGDU, P.R.
		STATE:			F4
		ZIP:			610041
		BUSINESS PHONE:		0086-028-86154737

	MAIL ADDRESS:	
		STREET 1:		23RD FLOOR, UNIONSUN YANGKUO PLAZA
		STREET 2:		NO.2, BLOCK 3, RENMIN ROAD SOUTH
		CITY:			CHENGDU, P.R.
		STATE:			F4
		ZIP:			610041

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VISCORP, INC.
		DATE OF NAME CHANGE:	20060515
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0603</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001362718</cik>
        <entityName>TIANYIN PHARMACEUTICAL CO., INC.</entityName>
        <issuerAddress>
            <street1>23RD FLOOR, UNIONSUN YANGKUO PLAZA</street1>
            <street2>NO.2, BLOCK 3, RENMIN ROAD SOUTH</street2>
            <city>CHENGDU, P.R.</city>
            <stateOrCountry>F4</stateOrCountry>
            <zipCode>610041</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>0086-028-86154737</issuerPhoneNumber>
        <jurisdictionOfInc>DELAWARE</jurisdictionOfInc>
        <edgarPreviousNameList>
            <previousName>VISCORP, INC.</previousName>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Quoqing</firstName>
                <lastName>Jiang</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>23 Floor, Unionson Yangkuo Plaza, No.2,</street1>
                <street2>South Renmin Road</street2>
                <city>Chengdu</city>
                <stateOrCountry>F4</stateOrCountry>
                <zipCode>610041</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Other</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>$1,000,001 - $5,000,000</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2009-10-27</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isOptionToAcquireType>true</isOptionToAcquireType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>3500000</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>5000000</totalOfferingAmount>
            <totalAmountSold>5000000</totalAmountSold>
            <totalRemaining>0</totalRemaining>
            <clarificationOfResponse></clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>8</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>495250</dollarAmount>
                <isEstimate>true</isEstimate>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse></clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>TIANYIN PHARMACEUTICAL CO., INC.</issuerName>
                <signatureName>Dr. Quoqing Jiang</signatureName>
                <nameOfSigner>Dr. Quoqing Jiang</nameOfSigner>
                <signatureTitle>CEO</signatureTitle>
                <signatureDate>2009-11-20</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----